Cronos expands Spinach STIX pre-rolls across Canada
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cronos Group Inc (CRON)
Cronos Group Inc stock price live, this page displays NASDAQ CRON stock exchange data. View the CRON premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cronos Group Inc real time stock price chart below.
What Is the Cronos Group Inc Stock Price Today?
The Cronos Group Inc stock price today is 2.650.
What Is the Stock Symbol for Cronos Group Inc?
The stock symbol for Cronos Group Inc is "CRON."
What Stock Exchange Does Cronos Group Inc Trade On?
Cronos Group Inc is listed and trades on the NASDAQ stock exchange.
Is Cronos Group Inc a Good Stock to Buy?
Determining whether Cronos Group Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRON quote. (ISIN: CA22717L1013) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the Cronos Group Inc Stock Price Today?
The Cronos Group Inc stock price today is 2.650.
What Is the Stock Symbol for Cronos Group Inc?
The stock symbol for Cronos Group Inc is "CRON."
What Stock Exchange Does Cronos Group Inc Trade On?
Cronos Group Inc is listed and trades on the NASDAQ stock exchange.
Is Cronos Group Inc a Good Stock to Buy?
Determining whether Cronos Group Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRON quote. (ISIN: CA22717L1013) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
Currency in USD
2.650
+0.020(+0.76%)
Real-time Data·
Fair Value
An estimate of a Cronos's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.615
2.660
52 wk Range
1.840
3.430
Earnings results expected in 5 days
1/2
Fair Value
An estimate of a Cronos's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.6152.660
52 wk Range
1.8403.430
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CRON Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cronos's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Cronos receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form DEF 14A CRONOS GROUP INC. For: 24 April
- Investing.com
- Cronos expands Spinach STIX pre-rolls across Canada
- Investing.com
- Form DEF 14A CRONOS GROUP INC. For: 24 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Cronos Group Inc Earnings Call Summary for Q4/2025
- Q4 2025 revenue of $44.53M (+47% YoY) missed forecast by $170K, sending stock down 3.97% to $2.66 in premarket trading
- Gross profit reached $16.2M with 36% margin (up 670bps); adjusted EBITDA improved $7.7M YoY to $0.5M; $832M cash, zero debt
- Company projects negative EPS of -$0.04 and -$0.05 for Q3/Q4 2026, with analysts forecasting continued unprofitability near-term
- CEO Gorenstein emphasized product innovation and market expansion in Europe/Canada despite supply chain and production quality challenges
- Operating expenses rose slightly to $22.5M; management focused on balancing demand with margin optimization amid regulatory uncertainty
Last Updated: 26/02/2026, 15:22
Read Full TranscriptEarnings
Latest Release
Feb 26, 2026
EPS / Forecast
0.02 / 0.02
Revenue / Forecast
44.53M / 44.7M
Compare CRON to Peers and Sector
Metrics to compare | CRON | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCRONPeersSector | |
|---|---|---|---|---|
P/E Ratio | −105.2x | −1.1x | −0.5x | |
PEG Ratio | 0.86 | 0.00 | 0.00 | |
Price/Book | 0.9x | 1.1x | 2.6x | |
Price / LTM Sales | 6.8x | 1.2x | 3.2x | |
Upside (Analyst Target) | −12.2% | 61.6% | 47.8% | |
Fair Value Upside | Unlock | 25.7% | 5.9% | Unlock |
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Cronos (CRON) Stock Price Today?
The Cronos stock price today is 2.650 USD.
What Stock Exchange Does Cronos Trade On?
Cronos is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Cronos?
The stock symbol for Cronos is "CRON."
What Is the Cronos Market Cap?
As of today, Cronos market cap is 987.710M USD.
What Is Cronos's Earnings Per Share (TTM)?
The Cronos EPS (TTM) is -0.025.
When Is the Next Cronos Earnings Date?
Cronos will release its next earnings report on May 11, 2026.
From a Technical Analysis Perspective, Is CRON a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Cronos Stock Split?
Cronos has split 0 times.
How Many Employees Does Cronos Have?
Cronos has 610 employees.
What is the current trading status of Cronos (CRON)?
As of May 06, 2026, Cronos (CRON) is trading at a price of 2.650 USD, with a previous close of 2.630 USD. The stock has fluctuated within a day range of 2.615 USD to 2.660 USD, while its 52-week range spans from 1.840 USD to 3.430 USD.
What Is the CRON Premarket Price?
CRON's last pre-market stock price is 2.640 USD. The pre-market share volume is 4,560.000, and the stock has decreased by 0.010, or 0.380%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.